FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052173238> ?p ?o ?g. }

• W2052173238 endingPage "887" @default.
• W2052173238 startingPage "883" @default.
• W2052173238 abstract "The ability of HIV to establish a latent infection causes life-long virus persistence, even after long-term highly active antiretroviral therapy (HAART). The role that latency is playing in preventing clearance of the virus infection has become evident in recent years. Patients who have been successfully treated with ART, having undetectable levels of viral RNA (below 50 copies/ml) in the plasma for years, experienced rapid virus rebound on withdrawal of therapy. Activation of latent proviruses from the infected cells in combination with ART is a therapeutic strategy that may lead to the complete elimination of HIV infection. We report here that suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor that has been approved for the treatment of cutaneous T cell lymphoma (CTCL), can activate an HIV-1 vector provirus in a cell model system. Treatment of cells harboring a latent, HIV-1-derived provirus caused activation of both early and late viral gene expression, acetylation of nucleosome on the 5’ long terminal repeat (LTR), and remodeling of the chromatin at the 5’ LTR. Several compounds, including valproic acid, have been tested for their ability to activate latent HIV-1, but have met with disappointing results. SAHA, a relatively nontoxic, FDA-approved compound, should be considered for developing a strategy to eliminate HIV from patients." @default.
• W2052173238 created "2016-06-24" @default.
• W2052173238 creator A5005881323 @default.
• W2052173238 creator A5023437330 @default.
• W2052173238 creator A5044685010 @default.
• W2052173238 creator A5067721961 @default.
• W2052173238 date "2009-09-01" @default.
• W2052173238 modified "2023-09-28" @default.
• W2052173238 title "Short Communication: Activation of Latent HIV Type 1 Gene Expression by Suberoylanilide Hydroxamic Acid (SAHA), an HDAC Inhibitor Approved for Use to Treat Cutaneous T Cell Lymphoma" @default.
• W2052173238 cites W1497870368 @default.
• W2052173238 cites W1527634862 @default.
• W2052173238 cites W1549854676 @default.
• W2052173238 cites W1590436404 @default.
• W2052173238 cites W1996604523 @default.
• W2052173238 cites W2001356550 @default.
• W2052173238 cites W2008685835 @default.
• W2052173238 cites W2034488184 @default.
• W2052173238 cites W2046934643 @default.
• W2052173238 cites W2064743809 @default.
• W2052173238 cites W2078221753 @default.
• W2052173238 cites W2084326063 @default.
• W2052173238 cites W2086384126 @default.
• W2052173238 cites W2087966689 @default.
• W2052173238 cites W2102824612 @default.
• W2052173238 cites W2106051882 @default.
• W2052173238 cites W2107815011 @default.
• W2052173238 cites W2113318324 @default.
• W2052173238 cites W2114546337 @default.
• W2052173238 cites W2118356577 @default.
• W2052173238 cites W2122745942 @default.
• W2052173238 cites W2125284130 @default.
• W2052173238 cites W2125878780 @default.
• W2052173238 cites W2149379768 @default.
• W2052173238 cites W2149767613 @default.
• W2052173238 cites W2166861522 @default.
• W2052173238 cites W2167415368 @default.
• W2052173238 doi "https://doi.org/10.1089/aid.2008.0294" @default.
• W2052173238 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2828260" @default.
• W2052173238 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19689202" @default.
• W2052173238 hasPublicationYear "2009" @default.
• W2052173238 type Work @default.
• W2052173238 sameAs 2052173238 @default.
• W2052173238 citedByCount "67" @default.
• W2052173238 countsByYear W20521732382012 @default.
• W2052173238 countsByYear W20521732382013 @default.
• W2052173238 countsByYear W20521732382014 @default.
• W2052173238 countsByYear W20521732382015 @default.
• W2052173238 countsByYear W20521732382016 @default.
• W2052173238 countsByYear W20521732382017 @default.
• W2052173238 countsByYear W20521732382018 @default.
• W2052173238 countsByYear W20521732382020 @default.
• W2052173238 countsByYear W20521732382021 @default.
• W2052173238 countsByYear W20521732382022 @default.
• W2052173238 crossrefType "journal-article" @default.
• W2052173238 hasAuthorship W2052173238A5005881323 @default.
• W2052173238 hasAuthorship W2052173238A5023437330 @default.
• W2052173238 hasAuthorship W2052173238A5044685010 @default.
• W2052173238 hasAuthorship W2052173238A5067721961 @default.
• W2052173238 hasBestOaLocation W20521732382 @default.
• W2052173238 hasConcept C102906071 @default.
• W2052173238 hasConcept C104317684 @default.
• W2052173238 hasConcept C140704245 @default.
• W2052173238 hasConcept C141231307 @default.
• W2052173238 hasConcept C159047783 @default.
• W2052173238 hasConcept C203014093 @default.
• W2052173238 hasConcept C2522874641 @default.
• W2052173238 hasConcept C2776202225 @default.
• W2052173238 hasConcept C2778305200 @default.
• W2052173238 hasConcept C2778852064 @default.
• W2052173238 hasConcept C2779338263 @default.
• W2052173238 hasConcept C2910737674 @default.
• W2052173238 hasConcept C502942594 @default.
• W2052173238 hasConcept C55493867 @default.
• W2052173238 hasConcept C64927066 @default.
• W2052173238 hasConcept C71924100 @default.
• W2052173238 hasConcept C86803240 @default.
• W2052173238 hasConceptScore W2052173238C102906071 @default.
• W2052173238 hasConceptScore W2052173238C104317684 @default.
• W2052173238 hasConceptScore W2052173238C140704245 @default.
• W2052173238 hasConceptScore W2052173238C141231307 @default.
• W2052173238 hasConceptScore W2052173238C159047783 @default.
• W2052173238 hasConceptScore W2052173238C203014093 @default.
• W2052173238 hasConceptScore W2052173238C2522874641 @default.
• W2052173238 hasConceptScore W2052173238C2776202225 @default.
• W2052173238 hasConceptScore W2052173238C2778305200 @default.
• W2052173238 hasConceptScore W2052173238C2778852064 @default.
• W2052173238 hasConceptScore W2052173238C2779338263 @default.
• W2052173238 hasConceptScore W2052173238C2910737674 @default.
• W2052173238 hasConceptScore W2052173238C502942594 @default.
• W2052173238 hasConceptScore W2052173238C55493867 @default.
• W2052173238 hasConceptScore W2052173238C64927066 @default.
• W2052173238 hasConceptScore W2052173238C71924100 @default.
• W2052173238 hasConceptScore W2052173238C86803240 @default.
• W2052173238 hasIssue "9" @default.
• W2052173238 hasLocation W20521732381 @default.
• W2052173238 hasLocation W20521732382 @default.
• W2052173238 hasLocation W20521732383 @default.
• W2052173238 hasLocation W20521732384 @default.

• next